Differences in DVT Rates in Patients Treated With and Without Preoperative Chemotherapy Prior to Distal Pancreatectomy: Is It the Therapy or Disease Burden?

Overview

Journal Ann Surg Oncol

Publisher Springer

Specialty Oncology

Date 2024 Jan 20

PMID 38245653

Authors

Joshua N Herb

Rebecca A Snyder

Affiliations

Soon will be listed here.

References

Gould M, Garcia D, Wren S, Karanicolas P, Arcelus J, Heit J . Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012; 141(2 Suppl):e227S-e277S. PMC: 3278061. DOI: 10.1378/chest.11-2297. View

Clancy T, Baker E, Maegawa F, Raoof M, Winslow E, House M . AHPBA guidelines for managing VTE prophylaxis and anticoagulation for pancreatic surgery. HPB (Oxford). 2022; 24(5):575-585. DOI: 10.1016/j.hpb.2021.12.010. View

Beal E, Tumin D, Chakedis J, Porter E, Moris D, Zhang X . Identification of patients at high risk for post-discharge venous thromboembolism after hepato-pancreato-biliary surgery: which patients benefit from extended thromboprophylaxis?. HPB (Oxford). 2018; 20(7):621-630. DOI: 10.1016/j.hpb.2018.01.004. View

Tzeng C, Katz M, Lee J, Fleming J, Pisters P, Vauthey J . Predicting the risks of venous thromboembolism versus post-pancreatectomy haemorrhage: analysis of 13,771 NSQIP patients. HPB (Oxford). 2013; 16(4):373-83. PMC: 3967890. DOI: 10.1111/hpb.12148. View

Kamiya M, Kawahara S, Kamioka Y, Murakawa M, Aoyama T, Kobayashi S . Incidence and Risk of Venous Thromboembolism in Patients With Resectable Pancreatic Cancer Receiving Neoadjuvant Chemotherapy. Anticancer Res. 2023; 43(4):1741-1747. DOI: 10.21873/anticanres.16327. View

Robbins K, Newcomer Jr K, Barnell E, Anzelmo M, Liu J, Hawkins W . Neoadjuvant Chemotherapy is Associated with Increased Risk of Postoperative DVT After Distal Pancreatectomy for Pancreatic Adenocarcinoma: a NSQIP Analysis. Ann Surg Oncol. 2023; 31(5):2873-2881. DOI: 10.1245/s10434-023-14763-y. View

Boone B, Zenati M, Rieser C, Hamad A, Al-Abbas A, Zureikat A . Risk of Venous Thromboembolism for Patients with Pancreatic Ductal Adenocarcinoma Undergoing Preoperative Chemotherapy Followed by Surgical Resection. Ann Surg Oncol. 2019; 26(5):1503-1511. DOI: 10.1245/s10434-018-07148-z. View

Florecki K, Owodunni O, Kia M, Borja M, Holzmueller C, Lau B . What Does Venous Thromboembolism Mean in the National Surgical Quality Improvement Program?. J Surg Res. 2020; 251:94-99. DOI: 10.1016/j.jss.2020.01.011. View

Czosnyka N, Borgert A, Smith T . Pancreatic adenocarcinoma: effects of neoadjuvant therapy on post-pancreatectomy outcomes - an American College of Surgeons National Surgical Quality Improvement Program targeted variable review. HPB (Oxford). 2017; 19(10):927-932. DOI: 10.1016/j.hpb.2017.07.001. View

10.

Dahdaleh F, Naffouje S, Hanna M, Salti G . Impact of Neoadjuvant Systemic Therapy on Pancreatic Fistula Rates Following Pancreatectomy: a Population-Based Propensity-Matched Analysis. J Gastrointest Surg. 2020; 25(3):747-756. DOI: 10.1007/s11605-020-04581-y. View

11.

Krell R, McNeil L, Yanala U, Are C, Reames B . Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma: Propensity-Matched Analysis of Postoperative Complications Using ACS-NSQIP. Ann Surg Oncol. 2021; 28(7):3810-3822. DOI: 10.1245/s10434-020-09460-z. View

12.

Eurola A, Mustonen H, Mattila N, Lassila R, Haglund C, Seppanen H . Preoperative oncologic therapy and the prolonged risk of venous thromboembolism in resectable pancreatic cancer. Cancer Med. 2022; 11(7):1605-1616. PMC: 8986147. DOI: 10.1002/cam4.4397. View

13.

Hue J, Elshami M, Beckman M, Driedger M, Rothermel L, Hardacre J . A Propensity-Matched Analysis of the Postoperative Venous Thromboembolism Rate After Pancreatoduodenectomy Based on Operative Approach. J Gastrointest Surg. 2021; 26(3):623-634. DOI: 10.1007/s11605-021-05191-y. View

14.

Herb J, Iwai Y, Dunham L, Stitzenberg K . Persistent underuse of extended venous thromboembolism prophylaxis in patients undergoing major abdominal cancer operations. J Surg Oncol. 2023; 129(2):436-443. DOI: 10.1002/jso.27473. View

15.

Mavros M, Johnson L, Schootman M, Orcutt S, Peng C, Martin B . Adherence to Extended Venous Thromboembolism Prophylaxis and Outcomes After Complex Gastrointestinal Oncologic Surgery. Ann Surg Oncol. 2023; 30(9):5522-5531. PMC: 10409669. DOI: 10.1245/s10434-023-13677-z. View

16.

Guntupalli S, Brennecke A, Behbakht K, Tayebnejad A, Breed C, Babayan L . Safety and Efficacy of Apixaban vs Enoxaparin for Preventing Postoperative Venous Thromboembolism in Women Undergoing Surgery for Gynecologic Malignant Neoplasm: A Randomized Clinical Trial. JAMA Netw Open. 2020; 3(6):e207410. PMC: 7320298. DOI: 10.1001/jamanetworkopen.2020.7410. View